Ethics approval and consent to participate
This prospective, randomized, controlled, double-blinded trial was approved by the institutional review board of Xuanwu Hospital, Capital Medical University (LYS [2019]051) and registered with the Chinese Clinical Trial Registry (ChiCTR1900025241). All participants provided verbal and written informed consent. We carried out the study in full accordance with the Declaration of Helsinki.